BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15194121)

  • 1. A Jekyll and Hyde kinase: roles for Cdk5 in brain development and disease.
    Cruz JC; Tsai LH
    Curr Opin Neurobiol; 2004 Jun; 14(3):390-4. PubMed ID: 15194121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk5: mediator of neuronal death and survival.
    Cheung ZH; Ip NY
    Neurosci Lett; 2004 May; 361(1-3):47-51. PubMed ID: 15135890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
    Zheng YL; Kesavapany S; Gravell M; Hamilton RS; Schubert M; Amin N; Albers W; Grant P; Pant HC
    EMBO J; 2005 Jan; 24(1):209-20. PubMed ID: 15592431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase 5--a neuronal killer?
    Guo Q
    Sci Aging Knowledge Environ; 2003 Dec; 2003(50):pe36. PubMed ID: 14681576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
    Chen J; Wang ZF
    Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase-5 in neurodegeneration.
    Shelton SB; Johnson GV
    J Neurochem; 2004 Mar; 88(6):1313-26. PubMed ID: 15009631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin-dependent kinases in brain development and disease.
    Su SC; Tsai LH
    Annu Rev Cell Dev Biol; 2011; 27():465-91. PubMed ID: 21740229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk5: a multifaceted kinase in neurodegenerative diseases.
    Cheung ZH; Ip NY
    Trends Cell Biol; 2012 Mar; 22(3):169-75. PubMed ID: 22189166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal cyclin-dependent kinase 5 activity is critical for survival.
    Tanaka T; Veeranna ; Ohshima T; Rajan P; Amin ND; Cho A; Sreenath T; Pant HC; Brady RO; Kulkarni AB
    J Neurosci; 2001 Jan; 21(2):550-8. PubMed ID: 11160434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
    Shelton SB; Krishnamurthy P; Johnson GV
    J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk5 in the adult non-demented brain.
    Fischer A; Sananbenesi F; Spiess J; Radulovic J
    Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):375-81. PubMed ID: 14683465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism.
    Grant P; Sharma P; Pant HC
    Eur J Biochem; 2001 Mar; 268(6):1534-46. PubMed ID: 11248670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons.
    Alvarez A; Muñoz JP; Maccioni RB
    Exp Cell Res; 2001 Apr; 264(2):266-74. PubMed ID: 11262183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdk5 at crossroads of protein oligomerization in neurodegenerative diseases: facts and hypotheses.
    Wilkaniec A; Czapski GA; Adamczyk A
    J Neurochem; 2016 Jan; 136(2):222-33. PubMed ID: 26376455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis.
    Bajaj NP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1(5):319-27. PubMed ID: 11464850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase 5 (CDK5) and neuronal cell death.
    Weishaupt JH; Neusch C; Bähr M
    Cell Tissue Res; 2003 Apr; 312(1):1-8. PubMed ID: 12684868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
    Kesavapany S; Zheng YL; Amin N; Pant HC
    Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.